Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
Daphné Denis,1 Nathalie Beneton,1 Kamel Laribi,2 Hervé Maillard1 1Dermatology Department, Centre Hospitalier Le Mans, Le Mans, France; 2Haematology Department, Centre Hospitalier Le Mans, Le Mans, France Abstract: Mycosis fungoides (MF) is a low-grade cutaneous lymphoma account...
Main Authors: | Denis D, Beneton N, Laribi K, Maillard H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/management-of-mycosis-fungoides-type-cutaneous-t-cell-lymphoma-mf-ctcl-peer-reviewed-article-CMAR |
Similar Items
-
Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation
by: Silvia Alberti-Violetti, et al.
Published: (2024-01-01) -
Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases
by: Marco Ardigò, et al.
Published: (2024-01-01) -
Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides
by: Larisa Geskin, et al.
Published: (2024-01-01) -
Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects#
by: Hadas Prag Naveh, et al.
Published: (2022-05-01) -
Utility of T-cell immunosequencing in distinguishing mycosis fungoides progression from treatment related cutaneous adverse events
by: Safiyyah Bhatti, et al.
Published: (2023-12-01)